Skip to main content

Lux Capital — Portfolio, Page 16

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

411
Companies
$23.0B
Total invested
$57.3M
Avg. check
62
Industries
Biotechnology 7Software 7Health Care 7Artificial Intelligence (AI) 5Life Science 4Information Technology 3+56 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 361–384 of 411
Anagenex
June 2022

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Biotechnology · Lexington$30.0M Series A
LatchBio
June 2022

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.

Artificial Intelligence (AI) · San Francisco$28.0M Series A
Vendia
May 2022

Power AI with all your data. Turn your enterprise data, assets, and services into AI-powered outcomes seamlessly and securely.

Artificial Intelligence (AI) · San Francisco$30.0M Series B
Miga
May 2022

Miga is a virtual cardiometabolic clinic that combines a gamified app (akin to Duolingo) with clinical services.

Fitness · San Francisco$12.0M Seed
Neptune Mutual
May 2022

Neptune Mutual platform explores new avenues to creating user-centric hedging products on the blockchain.

Blockchain · Winchester$5.3M Series Unknown
Desktop Metal
May 2022

Desktop Metal is a provider of metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers.

3D Printing · Burlington$100.0M Post Ipo Debt
Octant Bio
April 2022

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Biotechnology · Los Angeles$80.0M Series B
Cloaked
March 2022

Cloaked is a consumer-first privacy company that enables individuals to take control of their personal data with unlimited identities.

Internet · Boston$25.0M Series A
Creyon Bio
March 2022

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Biotechnology · San Diego$40.0M Series A
Aurora Solar
February 2022

Aurora Solar is a SaaS company that uses aerial imagery to assess solar installation projects.

Clean Energy · San Francisco$200.0M Series D
Balanced
February 2022

Balanced is an exercise platform for healthy aging that promises community, joy, and a personalized experience.

Fitness · Brooklyn$5.0M Seed
Gandeeva Therapeutics
January 2022

Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.

Artificial Intelligence (AI) · Vancouver$40.0M Series A
Mahana Therapeutics
January 2022

Mahana Therapeutics is a developer of digital treatments for people living with gastrointestinal conditions.

Health Care · San FranciscoNon Equity Assistance
Oasis Labs
January 2022

Oasis Labs is a privacy-first cloud computing platform on blockchain technology.

Blockchain · San FranciscoSeries Unknown
Decent
December 2021

Decent offers affordable healthcare by aligning incentives to improve health, reduce costs, and put members at the center of their care.

Health Care · San Francisco$1.0M Series A
Buf
November 2021

Buf is building tools to help companies completely change the way they work with APIs throughout their lifecycle.

Developer APIs · Toronto$68.0M Series B
Bild
October 2021

Build hardware faster. better. together.

Cloud Management · San Francisco$3.0M Seed
Clarifai
October 2021

Clarifai's platform supports the full AI development lifecycle; including dataset preparation, model training and deployment.

Artificial Intelligence (AI) · Fort Lee$60.0M Series C
Science 37
October 2021

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Biotechnology · Culver City$200.0M Post Ipo Equity
Copia Automation
October 2021

Copia automation brings DevOps tools to industrial automation.

DevOps · New York$14.2M Series A
AllStripes
August 2021

AllStripes is a healthcare technology company that accelerates drug development and research for the treatment of rare diseases.

Big Data · San Francisco$50.0M Series B
Hailify
August 2021

Hailify is a logistics company offering a B2B dispatch software solution to scale delivery operations.

B2B · New York$4.0M Seed
HiHello
July 2021

HiHello is a software company that builds next generation professional network that allows people to optimize their business relationships.

Apps · Palo Alto$7.5M Series A
Cape Analytics
July 2021

Cape Analytics provides AI and analytics services for properties.

Analytics · Palo Alto$44.0M Series C

Where Lux Capital invests

Biotechnology7
Software7
Health Care7
Artificial Intelligence (AI)5
Life Science4
Information Technology3

About Lux Capital's portfolio

How many companies has Lux Capital invested in?▸

Lux Capital has invested in 411 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Lux Capital invest in?▸

Lux Capital's top investment sectors include Biotechnology, Software, Health Care, Artificial Intelligence (AI), Life Science. The firm invests across 62 different industry categories.

What is Lux Capital's largest investment?▸

Among tracked funding rounds, Aurora Solar received $200.0M in a Series D round. Lux Capital's total known invested capital is $23.0B.

What is the average investment size for Lux Capital?▸

Lux Capital's average investment size is $57.3M across its portfolio of 411 companies.

What are Lux Capital's most recent investments?▸

Recent Lux Capital portfolio additions include Anagenex, LatchBio, Vendia, Miga, Neptune Mutual. These companies were founded in 2020 or later.

Reach the founders behind these 411 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →